Alexion Pharmaceuticals (ALXN) Sees Upside on Takeover Speculation
Tweet Send to a FriendGet Alerts ALXN Hot Sheet
Trade ALXN Now!
Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) is seeing upside action on takeover speculation.
FT Alphaville reported rumors that Roche could be weighing a bid for the company. The reports are very speculative in nature and is labeled as such. Nonetheless, shares of ALXN are up 3.8 percent mid-day to $106.23.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
FT Alphaville reported rumors that Roche could be weighing a bid for the company. The reports are very speculative in nature and is labeled as such. Nonetheless, shares of ALXN are up 3.8 percent mid-day to $106.23.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Alexion to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference
- Dover (DOV) Latest Diversified Industrial to Announce Streamlining; More to Follow?
- UPDATE: Sprint (S) to Raise Offer for Clearwire (CLWR) - DJ
Create E-mail Alert Related Categories
Rumors
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
